Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery.

Roche, CD; Brereton, RJL; Ashton, AW; Jackson, C; Gentile, C

Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery.

Roche, CD Brereton, RJL Ashton, AW Jackson, C Gentile, C

Permalink

Publisher:: OXFORD UNIV PRESS INC
Publication Type:: Journal Article
Citation:: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2020, 58, (3), pp. 500-510
Issue Date:: 2020-09

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.69 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Roche, CD
dc.contributor.author	Brereton, RJL
dc.contributor.author	Ashton, AW
dc.contributor.author	Jackson, C
dc.contributor.author	Gentile, C https://orcid.org/0000-0002-3689-4275
dc.date.accessioned	2020-11-23T20:01:51Z
dc.date.available	2020-02-18
dc.date.available	2020-11-23T20:01:51Z
dc.date.issued	2020-09
dc.identifier.citation	European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2020, 58, (3), pp. 500-510
dc.identifier.issn	1010-7940
dc.identifier.issn	1873-734X
dc.identifier.uri	http://hdl.handle.net/10453/144265
dc.description.abstract	SUMMARY:Previous attempts in cardiac bioengineering have failed to provide tissues for cardiac regeneration. Recent advances in 3-dimensional bioprinting technology using prevascularized myocardial microtissues as 'bioink' have provided a promising way forward. This review guides the reader to understand why myocardial tissue engineering is difficult to achieve and how revascularization and contractile function could be restored in 3-dimensional bioprinted heart tissue using patient-derived stem cells.
dc.format	Print
dc.language	eng
dc.publisher	OXFORD UNIV PRESS INC
dc.relation.ispartof	European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
dc.relation.isbasedon	10.1093/ejcts/ezaa093
dc.rights	info:eu-repo/semantics/openAccess
dc.rights	VC The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com European Journal of Cardio-Thoracic Surgery 58 (2020) 500–510 REVIEW doi:10.1093/ejcts/ezaa093 Advance Access publication 11 May 2020 Downloaded from https://academic.oup.com/ejcts/article/58/3/500/5835731 by guest on 30 November 2020
dc.subject	1102 Cardiorespiratory Medicine and Haematology
dc.subject.classification	Respiratory System
dc.title	Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery.
dc.type	Journal Article
utslib.citation.volume	58
utslib.location.activity	Germany
utslib.for	1102 Cardiorespiratory Medicine and Haematology
pubs.organisational-group	/University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
pubs.organisational-group	/University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	open_access	*
dc.date.updated	2020-11-23T20:01:47Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	58
utslib.citation.issue	3

Abstract:

SUMMARY:Previous attempts in cardiac bioengineering have failed to provide tissues for cardiac regeneration. Recent advances in 3-dimensional bioprinting technology using prevascularized myocardial microtissues as 'bioink' have provided a promising way forward. This review guides the reader to understand why myocardial tissue engineering is difficult to achieve and how revascularization and contractile function could be restored in 3-dimensional bioprinted heart tissue using patient-derived stem cells.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/144265